Report - Aspects pharmacologiques des - AEI › ... › 2012 › workshop › Solas-Pharmaco.pdf · En pratique: Cmin ~ 1100-2690 ng/ml (moyenne: 2030 ng/ml) >> CI 99 • 74% RVS (phase 2)

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form